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PURPOSE: To determine (i) the efficiency of radiosensitizing 5-FU-loaded
microspheres and (ii) the impact of microparticle formulation on response to
treatment.
METHODS: C6 tumor-bearing rats were stereotactically implanted with
microspheres and/or allocated to: control groups (untreated) or treatment (only
radiotherapy; fast-release 5-FU microspheres + radiotherapy; slow-release 5-FU
microspheres + radiotherapy). The next day, fractionated radiotherapy, limited to
the hemibrain, was initiated in all treated animals. The irradiation cycle included
36 Gy, given in 9 sessions for 3 consecutive weeks. Tumor development was
assessed by T2-weighted MRI.
RESULTS: 5-FU microspheres associated with radiotherapy caused a 47%
complete remission rate (9/19) as opposed to the 8% rate (1/12) when
radiotherapy alone or 0% in control animals. Drug delivery for 3 weeks produced
better survival results (57%) compared to one-week sustained release (41%). MR
images showed exponentially increasing tumor volumes during the first half of the
radiotherapy cycle, followed by a decrease, and the disappearance of the tumor if
survival exceeded 120 days.
CONCLUSIONS: 5-FU controlled delivery is a promising strategy for
radiosensitizing gliomas. Drug delivery system formulation is unambiguously
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